Misses from amyotrophic lateral sclerosis hopefuls Denali Therapeutics and partners AbbVie and Calico Life Sciences mark the latest setbacks for the controversial platform trial, the results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback